Precise vocal cord medialization using an adjustable laryngeal implant: a preliminary study.
Treatment of symptomatic unilateral vocal cord paralysis is most frequently surgical. Medialization of the vocal cord using Teflon injection has proved effective; however, studies have shown this technique to produce stiffness of the vocal fold with loss of the "mucosal wave" and concomitantly poor vocal function. As well, overcorrection may occur and is not reversible. Isshiki type 1 medialization thyroplasty has been shown to produce a substantial improvement in vocal quality, as well as preserve the mucosal wave. A number of problems encountered during the performance of Isshiki type 1 thyroplasty has led us to modify the original technique. We have developed a new implant that allows for precise, easily adjustable control of vocal cord medialization. To evaluate the degree of vocal cord medialization afforded by this implant, larynges of fresh male and female cadavers were used as an experimental model. In both larynges, vocal cord medialization was shown to occur in a predictable fashion for the anterior, middle, and posterior segments, as well as in the functionally important inter-arytenoid region. We believe the use of this implant in medialization thyroplasty will allow precise, atraumatic medialization of the paralyzed vocal cord. This greater control over positioning and ease of adjustment should contribute to enhanced vocal quality.
Desrosiers
M
M
Department of Otolaryngology-Head and Neck Surgery, Hospital Maisonneuve-Rosemont, Universite de Montreal, Quebec, Canada.
Ahmarani
C
C
Bettez
M
M
D002102:Cadaver; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008297:Male; D011138:Polytetrafluoroethylene; D019736:Prostheses and Implants; D013957:Thyroid Cartilage / Q000601:surgery; D014826:Vocal Cord Paralysis / Q000601:surgery*; D014827:Vocal Cords / Q000601:surgery
D011138:Polytetrafluoroethylene